28th Mar 2007 16:44
AstraZeneca PLC28 March 2007 Dealing by Directors Companies Act 1985 Sections 324/329 Transaction by Persons Discharging Managerial Responsibilities Disclosure Rules DR 3.1.2R We hereby inform you that the interest of David R. Brennan, a Director of theCompany, in the shares of AstraZeneca PLC has changed as detailed below. MrBrennan has interests in both the Ordinary Shares and the American DepositaryShares (ADSs) of AstraZeneca PLC. One ADS equals one Ordinary Share. On 26 March 2007, Mr Brennan became unconditionally entitled to a final award of15,566 ADSs on the partial vesting of an original target award of 28,826 ADSs,which were awarded to him in March 2004 under the terms of the AstraZeneca USExecutive Performance Share Plan. Mr Brennan has ceased to have an interest inthe 13,260 ADSs of the original target award that did not vest. After certainmandatory tax deductions, Mr Brennan has received 9,332 ADSs into a personalbrokerage account. The closing price of AstraZeneca ADSs on 26 March 2007 was US$54.73. Immediately prior to the above transactions, Mr Brennan had an interest in110,567 Ordinary Shares and 160,297 AstraZeneca ADSs. As a result of thesetransactions, Mr Brennan now has an interest in 110,567 Ordinary Shares and140,803 AstraZeneca ADSs. This interest represents approximately 0.017% of theCompany's issued ordinary capital. G H R Musker Company Secretary 28 March 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca